|
ANH is the removal of whole blood from a patient, while restoring the circulating blood volume with an acellular fluid shortly before an anticipated significant surgical blood loss. To minimize the manual labor associated with hemodilution, the blood should be collected in standard blood bags containing anticoagulant on a tilt-rocker with automatic cutoff via volume sensors. The blood is then stored at room temperature and reinfused during surgery after major blood loss has ceased, or sooner if indicated. Simultaneous infusions of crystalloid (3 mL crystalloid for each 1 mL of blood withdrawn) and colloid (dextrans, starches, gelatin, albumin [1 mL for each 1 mL of blood withdrawn]) have been recommended.[50] Blood units are reinfused in the reverse order of collection since the first unit collected; therefore the last unit transfused, has the highest hematocrit and concentration of coagulation factors and platelets. While this technique has been primarily developed and utilized in Europe, increasing interest in the United States has led to data [51] that show promise in the use of ANH as an alternative method of autologous blood procurement. Augmented hemodilution (replacement of ANH collected in part by synthetic oxygen carriers) is an integral part of many Phase III studies designed to obtain FDA approval for artificial oxygen carriers.
The chief benefit of ANH is the reduction of RBC losses when whole blood is shed perioperatively at lower hematocrit levels after ANH is completed. [52] Mathematical modeling has suggested that severe ANH to preoperative hematocrit levels of less than 20%, accompanied by substantial blood losses, would be required before the red
Figure 48-1
The relationship between whole blood volume (mL) lost
(abscissa) and red blood cell (RBC) volume lost (ordinate) in a 100-kg patient undergoing
hemodilution. RBC volume lost with 2800 mL whole blood lost intraoperatively after
hemodilution of 1500 mL whole blood (○-○). RBC volume lost with 2800 mL
whole blood lost during hemodilution at each of three 500 mL volumes (—).
Cumulative RBC volume lost intraoperatively, derived for 2800 mL whole blood lost
if hemodilution had not been performed (- - -). A net of 215 mL reduction in RBC
volume lost with hemodilution is illustrated by the divergence of the two curves.
(From Goodnough LT, Grishaber JE, Monk TG, et al: Acute normovolemic hemodilution
in patients undergoing radical suprapubic prostatectomy: A case study analysis.
Anesth Analg 78:932–937, 1994, with permission.)
The benefit of ANH as determined in a mathematical model[50] is illustrated in Figure 48-2 . An adult with an estimated 5-Liter blood volume and an initial hematocrit of 40%, with surgical blood losses of up to 3000 mL would result in a hematocrit level that would remain 25% postoperatively without an autologous blood intervention. This level is generally considered safe for patients without known risk factors. In this model, the performance of ANH with initial hematocrit levels of 40% to 45% would allow up to 2500 to 3500 mL surgical blood loss; yet the nadir level of hematocrit could be maintained at 28%.
Withdrawal of whole blood and replacement with crystalloid or colloid solution decreases arterial oxygen content, but compensatory hemodynamic mechanisms and the existence of surplus oxygen-delivery capacity make ANH safe. A sudden decrease in RBC concentration lowers
Figure 48-2
The maximum allowable blood loss in a patient with a
blood volume of 5,000 mL and an initial hematocrit level of 45% (the red lines) or
40% (the black and gray lines), with and without acute normovolemic hemodilution
(ANH). (From Goodnough LT, Brecher ME, Monk TG: Acute normovolemic hemodilution
in surgery. Hematology 2:413–420, 1992, with permission.)
Because blood collected by ANH is stored at room temperature and is usually returned to the patient within 8 hours of collection, there is little deterioration of platelets or coagulation factors. The hemostatic value of blood collected by ANH is of questionable benefit for orthopedic or urologic surgery because plasma and platelets are rarely indicated in this setting. Its value in protecting plasma and platelets from the acquired coagulopathy of extracorporeal circulation in cardiac surgery (known as "blood pooling") is better established.[57]
|